World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
84
Citations
22228
World Ranking
1398
National Ranking
93

Medicine

D-Index
84
Citations
22229
World Ranking
15258
National Ranking
810

Overview

Volker Schirrmacher is affiliated with the German Cancer Research Center in Germany and has contributed extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research primarily focuses on oncology and immunology, with significant work related to genetics, pulmonary and respiratory medicine, and neurology.

The scientist's key research topics include:

  • CAR-T cell therapy research
  • Virus-based gene therapy research
  • Glioma diagnosis and treatment
  • Immunotherapy and immune responses
  • Cancer immunotherapy and biomarkers
  • Brain metastases and treatment
  • Neuroblastoma research and treatments

Volker Schirrmacher has collaborated frequently with several coauthors, most notably Stefaan Van Gool, Wilfried Stuecker, Jennifer Makalowski, Tobias Sprenger, and Peter Van de Vliet.

The scientist's recent notable publications include:

  • Less Can Be More: The Hormesis Theory of Stress Adaptation in the Global Biosphere and Its Implications, 2021, Biomedicines
  • Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and Metabolism, 2020, Biomedicines
  • Cancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients than Other Systemic Therapies: A Comparative Analysis, 2020, Biomedicines
  • Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus, 2022, Biomedicines
  • Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged, 2020, Cancers

Volker Schirrmacher has published predominantly in journals such as Biomedicines and Neuro-Oncology, with additional articles appearing in the International Journal of Molecular Sciences, Cancers, and Medicines.

Best Publications

  • From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review)

    Volker Schirrmacher

  • Bone marrow as a priming site for T-cell responses to blood-borne antigen

    Markus Feuerer;Philipp Beckhove;Natalio Garbi;Yolanda Mahnke

  • THE REQUIREMENT OF MORE THAN ONE ANTIGENIC DETERMINANT FOR IMMUNOGENICITY

    Unknown

  • EGF receptor in neoplasia and metastasis.

    Khashayarsha Khazaie;Volker Schirrmacher;Rosemarie B. Lichtner

  • Lymphoma Cell-mediated Degradation of Sulfated Proteoglycans in the Subendothelial Extracellular Matrix: Relationship to Tumor Cell Metastasis

    I. Vlodavsky;Z. Fuks;M. Bar-Ner;Y. Ariav

  • Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow

    Markus Feuerer;Philipp Beckhove;Lianhua Bai;Erich Franz Solomayer

  • Cancer Metastasis: Experimental Approaches, Theoretical Concepts, and Impacts for Treatment Strategies

    Unknown

  • Human (HLA-A and HLA-B) and murine (H-2K and H-2D) histocompatibility antigens are cell surface receptors for Semliki Forest virus.

    Ari Helenius;Bror Morein;Erik Fries;Kai Simons

  • Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin

    J. Dennis;C. Waller;R. Timpl;V. Schirrmacher

  • Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis.

    Orit Goldshmidt;Eyal Zcharia;Rinat Abramovitch;Shula Metzger

  • Antitumor Vaccination of Patients With Glioblastoma Multiforme: A Pilot Study to Assess Feasibility, Safety, and Clinical Benefit

    Hans Herbert Steiner;Matteo Mario Bonsanto;Philipp Beckhove;Michael Brysch

  • Nitric-oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C release.

    Alexey Ushmorov;Frank Ratter;Volker Lehmann;Wulf Dröge

  • Different Patterns of Lectin Binding and Cell Surface Sialylation Detected on Related High- and Low-Metastatic Tumor Lines

    Peter Altevogt;Mina Fogel;Rachanee Cheingsong-Popov;Jim Dennis

  • Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo.

    V. Schirrmacher;G. Shantz;K. Cauer;D. Komitowski

  • Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase

    Mostafa Jarahian;Carsten Watzl;Philippe Fournier;Annette Arnold

  • Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus.

    V Schirrmacher;C Haas;R Bonifer;T Ahlert

  • Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients

    Markus Feuerer;Marian Rocha;Lianhua Bai;Victor Umansky

  • Further evidence for derepression of h-2 and ia-like specificities of foreign haplotypes in mouse tumour cell lines.

    Federico Garrido;Hilliard Festenstein;Volker Schirrmacher

  • High Frequencies of Functional Tumor-Reactive T Cells in Bone Marrow and Blood of Pancreatic Cancer Patients

    Friedrich H. Schmitz-Winnenthal;Christine Volk;Kaspar Z'graggen;Luis Galindo

  • Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors

    Philipp Beckhove;Markus Feuerer;Mathias Dolenc;Florian Schuetz

  • Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma.

    D Ockert;V Schirrmacher;N Beck;E Stoelben

  • Tumor selective replication of Newcastle Disease Virus: association with defects of tumor cells in antiviral defence.

    Christoph Fiola;Ben Peeters;Philippe Fournier;Annette Arnold

Frequent Co-Authors

Philipp Beckhove
Philipp Beckhove German Cancer Research Center
Peter Altevogt
Peter Altevogt German Cancer Research Center
Andreas Schneeweiss
Andreas Schneeweiss German Cancer Research Center
Peter M. Schlag
Peter M. Schlag Charité - University Medicine Berlin
Viktor Umansky
Viktor Umansky Heidelberg University
Israel Vlodavsky
Israel Vlodavsky Technion – Israel Institute of Technology
Jürgen Weitz
Jürgen Weitz TU Dresden
Gerhard Moldenhauer
Gerhard Moldenhauer German Cancer Research Center
Frank Momburg
Frank Momburg German Cancer Research Center
Bruno Kyewski
Bruno Kyewski German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA can open doors to diverse healthcare and research careers. For those interested in advancing clinical expertise, pursuing a Doctor of Nursing Practice (DNP) degree is a valuable option. Understanding the dnp salary by state helps graduates assess financial prospects across different locations.

Nurses looking to specialize further often consider transitioning from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner (ACNP). This move allows professionals to provide critical care services and expand their skill sets. Helpful insights can be found in guides on how to transition from FNP to ACNP.

For those pursuing faster routes to specialization, enrolling in accelerated np programs online offers flexible pathways to become a nurse practitioner. Additionally, individuals without a nursing background might explore online rn programs for non nurses in florida to start their healthcare journey with convenience and accessibility. These programs exemplify how evolving educational options support diverse student needs within the immunology and healthcare spectrum.

Best Scientists Citing Volker Schirrmacher

Trending Scientists

Recently Published Articles